LINC02757

Across TCGA pan-cancer cohorts, LINC02757 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated LINC02757 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC02757 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC02757 expression acts as an unfavorable survival marker, although some lineages such as LUAD and LIHC show a favorable association.

LUAD, MESO, and UCEC are the cancer types where LINC02757 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	All	0.854	0.769	.003	55	view →
MESO	DFS	Median	All	0.244	0.603	.006	39	view →
UCEC	DFS	Tertile	All	0.858	0.910	.004	36	view →
LAML	DFS	Quartile	All	0.206	0.517	<.001	34	view →
COAD	OS	Median	II,III,IV	0.755	0.892	.006	32	view →
LUSC	OS	Tertile	IV	0.057	0.852	.017	30	view →
ACC	OS	Quartile	II,III,IV	0.263	0.726	.010	25	view →
STAD	DFS	Quartile	All	0.451	0.588	.003	21	view →
THCA	OS	Quartile	IV	0.569	1.000	.006	15	view →
LIHC	DFS	Median	III,IV	0.591	0.239	.001	13	view →
SKCM	DFS	Tertile	IV	0.134	0.589	.031	12	view →
CESC	OS	Tertile	II,III,IV	0.724	0.850	.016	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

LINC02757–LUAD (OS)

Open the LUAD breakdown →